212 related articles for article (PubMed ID: 21679466)
1. Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma.
Ma J; Wang S; Zhao M; Deng XS; Lee CK; Yu XD; Liu B
BMC Cancer; 2011 Jun; 11():255. PubMed ID: 21679466
[TBL] [Abstract][Full Text] [Related]
2. Cladribine in combination with entinostat synergistically elicits anti-proliferative/anti-survival effects on multiple myeloma cells.
Wang B; Lyu H; Pei S; Song D; Ni J; Liu B
Cell Cycle; 2018; 17(8):985-996. PubMed ID: 29969371
[TBL] [Abstract][Full Text] [Related]
3. Cladribine and bendamustine exhibit inhibitory activity in dexamethasone-sensitive and -resistant multiple myeloma cells.
Cai B; Wang S; Huang J; Lee CK; Gao C; Liu B
Am J Transl Res; 2013; 5(1):36-46. PubMed ID: 23390564
[TBL] [Abstract][Full Text] [Related]
4. Janus activated kinase 2/signal transducer and activator of transcription 3 pathway mediates icariside II-induced apoptosis in U266 multiple myeloma cells.
Kim SH; Ahn KS; Jeong SJ; Kwon TR; Jung JH; Yun SM; Han I; Lee SG; Kim DK; Kang M; Chen CY; Lee JW; Kim SH
Eur J Pharmacol; 2011 Mar; 654(1):10-6. PubMed ID: 21172343
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells.
Park S; Lee HJ; Jeong SJ; Song HS; Kim M; Lee HJ; Lee EO; Kim DH; Ahn KS; Kim SH
Food Chem Toxicol; 2011 Jun; 49(6):1367-72. PubMed ID: 21420464
[TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide-enhanced, matrine-induced apoptosis in multiple myeloma cell lines.
Yu Q; Chen B; Zhang X; Qian W; Ye B; Zhou Y
Planta Med; 2013 Jun; 79(9):775-81. PubMed ID: 23700110
[TBL] [Abstract][Full Text] [Related]
7. HDAC inhibition synergistically enhances alkylator-induced DNA damage responses and apoptosis in multiple myeloma cells.
Lee CK; Wang S; Huang X; Ryder J; Liu B
Cancer Lett; 2010 Oct; 296(2):233-40. PubMed ID: 20447761
[TBL] [Abstract][Full Text] [Related]
8. [Mechanisms of cladribine-inducing apoptosis of multiple myeloma RPMI 8226 cells in vitro].
Zhou NC; Qi MY; Liu BL; Xu B; Liu X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Dec; 22(6):1644-8. PubMed ID: 25543490
[TBL] [Abstract][Full Text] [Related]
9. Metformin induces myeloma cells necrosis and apoptosis and it is considered for therapeutic use.
Wu Z; Wu L; Zou L; Wang M; Liu X
J Chemother; 2023 Apr; 35(2):131-141. PubMed ID: 35427214
[TBL] [Abstract][Full Text] [Related]
10. beta-lapachone, a novel plant product, overcomes drug resistance in human multiple myeloma cells.
Gupta D; Podar K; Tai YT; Lin B; Hideshima T; Akiyama M; LeBlanc R; Catley L; Mitsiades N; Mitsiades C; Chauhan D; Munshi NC; Anderson KC
Exp Hematol; 2002 Jul; 30(7):711-20. PubMed ID: 12135668
[TBL] [Abstract][Full Text] [Related]
11. Combination of bendamustine and entinostat synergistically inhibits proliferation of multiple myeloma cells via induction of apoptosis and DNA damage response.
Cai B; Lyu H; Huang J; Wang S; Lee CK; Gao C; Liu B
Cancer Lett; 2013 Jul; 335(2):343-50. PubMed ID: 23459296
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of apoptosis induced in vitro by cladribine (2-CdA) combined with anthracyclines in lymphocytes from patients with B-cell chronic lymphocytic leukemia.
Szmigielska-Kaplon A; Smolewski P; Najder M; Robak T
Ann Hematol; 2002 Sep; 81(9):508-13. PubMed ID: 12373351
[TBL] [Abstract][Full Text] [Related]
13. [Effect of 20 (S)-ginsenoside Rg3 on the proliferation inhibition and secretion of vascular endothelial growth factor of multiple myeloma cell line U266].
Song Y; Hou J; Kang L; Gao S
Zhonghua Xue Ye Xue Za Zhi; 2014 Jun; 35(6):519-23. PubMed ID: 24985176
[TBL] [Abstract][Full Text] [Related]
14. [Effect of Metformin on Proliferation of Multiple Myeloma Cells].
Lu B; Gui SY; Zhou HH; Liu ZL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Aug; 25(4):1097-1100. PubMed ID: 28823275
[TBL] [Abstract][Full Text] [Related]
15. 4-Chlorobenzoyl berbamine, a novel berbamine derivative, induces apoptosis in multiple myeloma cells through the IL-6 signal transduction pathway and increases FOXO3a-Bim expression.
Shen JK; Du HP; Ma Q; Yang M; Wang YG; Jin J
Oncol Rep; 2013 Jul; 30(1):425-32. PubMed ID: 23624712
[TBL] [Abstract][Full Text] [Related]
16. BAY-11-7082 induces apoptosis of multiple myeloma U266 cells through inhibiting NF-κB pathway.
Wang Y; Zhang XL; Sun CM
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2564-2571. PubMed ID: 29771406
[TBL] [Abstract][Full Text] [Related]
17. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines.
Nabhan C; Gajria D; Krett NL; Gandhi V; Ghias K; Rosen ST
Mol Cancer Ther; 2002 Nov; 1(13):1221-7. PubMed ID: 12479703
[TBL] [Abstract][Full Text] [Related]
18. Increased fatty acid synthase as a potential therapeutic target in multiple myeloma.
Wang WQ; Zhao XY; Wang HY; Liang Y
J Zhejiang Univ Sci B; 2008 Jun; 9(6):441-7. PubMed ID: 18543396
[TBL] [Abstract][Full Text] [Related]
19. [Apoptosis and re-expression of p16 gene in the myeloma cell line U266 induced by synergy of histone deacetylase inhibitor and demethylating agent].
Du HL; Qi Y; Shi YJ; Bu DF; Wu SL
Ai Zheng; 2002 Oct; 21(10):1057-61. PubMed ID: 12508642
[TBL] [Abstract][Full Text] [Related]
20. [MS-275, a histone deacetylase inhibitor, induces apoptosis and alters survivin gene expression in human myeloma cell line U266].
Ma J; Zhao M; Yu XD; Wang ZH
Ai Zheng; 2009 May; 28(5):466-71. PubMed ID: 19624872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
